Compound ID | 1341

Temocillin

Synonym(s): BRL 17421  |  BRL-17421  |  BRL17421  |  Negaban

Class: Beta-lactam

Agent Type: Semisynthetic; Small molecule; Direct acting;
Spectrum of activity: Gram-negative
Mechanism of action: Cell wall synthesis inhibitor. PBP-5 inhibitor and PBP-6 inhibitor
Institute where first reported: Beecham Pharmaceuticals (GSK, US)
Year first mentioned: 1982
Highest development stage: Approved in EU in 1980s (by UK in 2005)
Development status: Approved
Chemical structure(s):
Click here for structure editor
Molecular weight: 414.46
Iso. SMILES: CC1([C@@H](N2[C@H](S1)[C@@](C2=O)(NC(=O)C(C3=CSC=C3)C(=O)O)OC)C(=O)O)C
InChI Key: BVCKFLJARNKCSS-DWPRYXJFSA-N
Can. SMILES: CC1(C)[C@H](C(=O)O)N2C(=O)[C@]([C@H]2S1)(NC(=O)C(C3=CSC=C3)C(=O)O)OC
InChI: InChI=1S/C16H18N2O7S2/c1-15(2)9(12(22)23)18-13(24)16(25-3,14(18)27-15)17-10(19)8(11(20)21)7-4-5-26-6-7/h4-6,8-9,14H,1-3H3,(H,17,19)(H,20,21)(H,22,23)/t8?,9-,14+,16-/m0/s1

AntibioticDB is supported by GARDP.

If you have feedback, experience problems, or are interested in a collaboration, please contact us. | Terms and conditions

The content of this site is intended for educational and scientific research purposes only and not as a source of medical advice or consultation.